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Poxvirus vectors are extensively used as expression vehicles for protein and antigen expression in eukaryotic cells.
Customarily, the foreign DNA is introduced into the poxvirus genome by homologous recombination. An alternative method
using direct ligation vectors has been used to efficiently construct chimeric genomes in situations not readily amenable for
homologous recombination. We describe the construction and characterization of a new set of direct ligation vectors
designed to be universally applicable for the generation of chimeric vaccinia genomes. These vectors contain the pair of
unique restriction sites NotI and ApaI to eliminate religation of poxvirus arms and fix the orientation of the insert DNA
behind strongly expressing constitutive vaccinia promoters. The insertion cassette has been placed at the beginning of the
thymidine kinase gene in vaccinia to use drug selection in the isolation of recombinants. These viruses provide a set of
universally applicable direct ligation poxvirus cloning vectors, extending the utility of poxvirus vectors for construction and
expression of complex libraries. q 1997 Academic Press
INTRODUCTION and reintroducing a NotI site proximal to the thymidine
kinase gene such that insertion of a sequence at this
Their ease of cloning and propagation in a variety of
locus disrupts the thymidine kinase gene, allowing isola-
host cells has led to the widespread use of poxvirus
tion of chimeric genomes via use of drug selection
vectors for expression of foreign protein and as delivery
(Merchlinsky and Moss, 1992).
vehicles for vaccine antigens (Moss, 1991). Generally,
The direct ligation vector vNotI/tk allowed one to effi-
the target protein coding sequence is cloned behind a
ciently clone and propagate DNA inserts at least 26 kb
vaccinia promoter flanked by sequences homologous to
in length (Merchlinsky and Moss, 1992). Although large
a nonessential region in the poxvirus and the plasmid
DNA fragments were efficiently cloned into the genome,
intermediate is recombined into the viral genome by ho-
proteins encoded by the DNA insert will be expressed
mologous recombination. This methodology works effi-
only at the low level corresponding to the thymidine ki-
ciently for relatively small inserts tolerated by prokaryotic
nase gene, a relatively weakly expressed early class
hosts. The method becomes less viable in cases requir-
gene in vaccinia, and the DNA will be inserted in both
ing large inserts as the frequency of homologous recom-
orientations at the NotI site. Our aim was to modify the
bination is low and decreases with insert size; in cases
genome of vNotI/tk so as to acquire direct ligation vec-
requiring construction of labor-intensive plasmid inter-
tors that will be more universally useful. First, we decided
mediates such as in expression library production; and
to change the insertion site by placing the sites for two
in cases where the propagation of DNA is not tolerated
unique restriction enzymes at the beginning of the thymi-
in bacteria. In two laboratories, a direct ligation protocol
dine kinase gene. This allows one to fix the orientation
obviating the need for homologous recombination has
of the insert DNA and eliminates the production of con-
been developed to generate poxvirus chimeric genomes.
taminating wild-type genomes after religation of viral
The DNA from the genome was digested, ligated to insert
arms. Second, to generate a direct ligation vector that
DNA in vitro, and transfected into cells infected with a
would express high levels of protein we decided to pre-
helper virus (Merchlinsky and Moss, 1992; Scheiflinger
cede the thymidine kinase gene with a strong constitutive
et al., 1992). In one protocol, the genome was digested
vaccinia virus promoter.
at the unique NotI site and a DNA insert containing ele-
ments for selection or detection of the chimeric genomes
MATERIALS AND METHODSwas ligated to the genomic arms (Scheiflinger et al.,
1992). Alternatively, the vaccinia WR genome was modi- Plasmid construction
fied by removing the NotI site in the HindIII F fragment
Pairs of oligonucleotides were constructed that, when
annealed, contained the 7.5k gene promoter (MM436:1 To whom reprint requests should be addressed. Fax: (301) 480–
1597. E-mail: merchlinsky@cber.fda.gov. GGCCAAAAATTGAAAAACTAGATCTATTTATTGCA-
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CGCGGCCGCCATGGGCCC, MM437: GGCCGGGCCC- Moss, 1991) or HAT supplemented medium (Weir et al.,
1982) as described in the text.ATGGCGGCCGCGT GCAAT AAATAGAT CTAGT TT-
TTCAATTTTT) or the synthetic EL promoter (MM438: Vaccinia virus was generated from viral DNA by rescue
with fowlpox virus (Scheiflinger et al., 1992). VacciniaGGCCAAAAATTGAAATTTTATTTTTTTTTTTTGGAATA-
TAAAGCGGCCGCCATGGGCCC, MM439: GGCCGG- virus was isolated from infected HeLa cells by banding
and sedimentation in sucrose (Earl and Moss, 1991). TheGCCCATGGCGGCCGCTTTATATTCCAAAAAAAAAAA-
ATAAAATTTCAATTTTT) and restriction sites for NotI and purified virions were treated with proteinase K (Boeh-
ringer-Mannheim), gently extracted with buffer-saturatedApaI. The double-stranded oligonucleotides were an-
nealed by ramping from 947 to 207 over 2 h and ligated phenol, phenol:chloroform (50:50), and chloroform before
precipitation with 2.5 vol of ethanol in 0.3 M sodium(New England Biolabs) into the NotI site present in
pJNotI/tk, a plasmid containing the HindIII J fragment acetate, and resuspended in TE (10 mM Tris–HCl, pH
8.0, 1 mM EDTA (Earl and Moss, 1991). Confluent wellsfrom vNotI/tk, resulting in plasmids p7.5/tk and pEL/tk.
A polymerase chain reaction (PCR) was performed on of BSC-1 cells from a 12-well dish were infected with
fowlpox virus and, after a 2-h incubation at 377C, werepBI221 (Clontech), a plasmid containing the Escherichia
coli gusA gene encoding for b-glucuronidase (b-glu), us- transfected with 0.6 mg full-length vaccinia DNA using
Lipofectamine as suggested by the manufacturer. Aftering primers MM440 (GGGAAAGGGGCGGCCGCCATG-
TTACGTCCTGTAGAAACC) and MM441 (GGGAAAGGG- incubation (usually 72 h), the cells were harvested, lysed
by three freeze–thaw cycles, and screened by plaqueGGGCCCTCATTGTTTGCCTCCCTGCTG), or MM440 and
MM442 (GGGAAAGGGGCGGCCGCCTCATTGTTTGCC- assay on BSC-1 cells (Earl and Moss, 1991).
TCCCTGCTG), and the resulting fragment was cloned
Generation of recombinant viruses by direct ligationinto pCRII (TA cloning kit, Invitrogen). The plasmids were
excised with NotI (MM440/MM442 product) and cloned
The 1.1-kB EcoRI/EcoRV restriction endonuclease
into pJNot/tk digested with NotI yielding pJNot/tk-GUS,
fragment containing ovalbumin from pHbeta-Ova-neo
or excised with NotI and ApaI (MM440/MM441 product)
(Pulaski et al., 1996) was inserted into the EcoRI and
and inserted into pEL/tk and p7.5/tk previously digested
EcoRV sites of pBluescript KS/ (Stratagene), generating
with ApaI and NotI, yielding p7.5/tk-GUS and pEL/tk-GUS.
pBS.ova. The DNA product from a PCR on pBS.ova using
Pairs of oligonucleotides were constructed that, when
primers VV0LZ5 (GCAGGTGCGGCCGCCGTGGATCCC-
annealed, contained the 7.5k gene promoter and the nu-
CCGGGCTGCAGG) and VVTLZ3 (GTACCGGGCCCA-
cleotide sequence encoding for a cytotoxic T-cell epitope
CAAAAACAAAATTAGTTAGTTAGGCCCCCCCTCGA)
for ovalbumin (Moore et al., 1988) (SIINFEKL) (75ova:
was digested with ApaI and NotI (Life Technologies Inc.),
GGCCAAAAATTGAAAAACTAGATCTATTTATTGCACCAT -
gel purified from low-melting-point agarose (Bio-Rad) us-
GAGTATAATCAACTTTGAAAAACTGTAGTGA, 75ovarv:
ing b-Agarase (Life Technologies, Inc.) following the rec-
GGCCTCACTACAGTTTTTCAAAGTTGATTAATACTCATG -
ommendations of the manufacturer, and cloned into
GTGCAATAAATAGATCTAGTTTTTCAATTTTT) or the EL
pBluescript KS/ that had been digested with NotI and
promoter and the peptide SIINFEKL (ELova: GGCCAA-
ApaI, generating pBS.VVova. A DNA fragment encoding
AAATTGAAATTTTATTTTTTTTTTTTGGAATATAAACCA-
ovalbumin was excised from pBS.VVova by digestion of
TGAGTATAATCAACTTTGAAAAACTGTAGTGA, ELovarv:
this plasmid with ApaI and NotI and purified after electro-
GGCCTCACTACAGTTTTTCAAAGTTGATTATACTCATG-
phoresis through a low-melting-point agarose gel using
GTTTATATTCCAAAAAAAAAAAATAAAATTTCAATTTTT).
b-Agarase. One microgram of purified vEL/tk DNA was
The double-stranded oligonucleotides were annealed by
digested with ApaI and NotI and centrifuged through a
ramping from 947 to 207 over 2 h and ligated into the NotI
Centricon 100 concentrator (Amicon) to remove the small
site present in pJNotI/tk, a plasmid containing the HindIII
intervening fragment. The vEL/tk DNA arms and the DNA
J fragment from vNotI/tk, resulting in plasmids p7.5/tk-
fragment encoding ovalbumin were ligated overnight at
ova and pEL/tk-ova.
room temperature, at a 4:1 (insert: virus) molar ratio, in
30 ml with 5 units T4 DNA ligase. The ligation product
Generation of recombinant viruses was transfected using Lipofectamine into a well of con-
fluent BSC-1 cells from a 12-well plate 2 h after infection
Cells and viruses were maintained and manipulated
with fowlpox virus at 1 PFU/cell. Three days later the
as previously described (Earl and Moss, 1991). Recombi-
cells were harvested and isolated plaques were selected
nant viruses were made using homologous recombina-
by passage in Hutk cells in the presence of bromodeoxy-
tion by infecting CV-1 cells at a m.o.i. of 0.05 and, 2
uridine (Earl and Moss, 1991).
h later, transfecting DNA into the infected cells using
Lipofectamine (Life Technologies Inc.) as suggested by Analysis of viral DNA genomes
the manufacturer. After 72 h the cells were harvested
and isolated plaques were selected by passage in Hutk0 BSC-1 cells were infected at approximately 10 PFU per
cell by vaccinia WR, vEL/tk, v7.5/tk, or vNotI/tk. After 24cells in the presence of bromodeoxyuridine (Earl and
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h the cells were harvested and resuspended in cell sus- RESULTS
pension buffer (Bio-Rad Genomic DNA Plug Kit) at 1 1
Construction of direct ligation vectors
107 cells/ml. An equal volume of 2% CleanCut agarose
The vaccinia WR genome is approximately 190 kb in(Bio-Rad) preincubated at 507 was added and the cell
length and rich in A and T residues. The complete se-suspension was formed into 100-ml plugs. After harden-
quence of the vaccinia WR genome was provided by theing at 47 the plugs were treated as previously described
Bernard Moss laboratory (P. Earl, personal communica-to digest protein (Merchlinsky and Moss, 1989). The
tion) and a restriction enzyme search of the genomeplugs were equilibrated in the appropriate restriction en-
using MacVector (IBI) revealed a lack of restriction siteszyme buffer and 1 mM phenylmethylsulfonyl fluoride
for ApaI, AscI, Bsp120I, FseI, RsrII, SfiI, SrfI, and SgfI. The(PMSF) for 16 h at room temperature and incubated with
ready availability of highly active and pure preparationsrestriction enzyme buffer, 100 ng/ml bovine serum albu-
of the enzyme as well as the generation of a staggeredmin, and 50 units NotI or ApaI for 2 h at 377 (NotI) or
end on digestion led us to choose to use ApaI as theroom temperature (ApaI) prior to electrophoresis.
second site in conjunction with the NotI site already pres-
ent in vNot/tk.
Determination of b-glucuronidase activity Vaccinia virus-based expression vectors are most use-
ful when the foreign protein is expressed constitutively.
A well of BSC-1 cells from a 12-well plate was infected The expression of foreign proteins during the early stage
at a m.o.i. of 1 with vNotI/tk-GUS, v7.5/tk-GUS, and vEL/ of viral replication is essential for cytotoxic T-cell re-
tk-GUS; the cells were harvested 20 h postinfection, re- sponse (Bennick and Yewdell, 1990) and high levels of
suspended in 0.5 ml PBS, and disrupted by three cycles total protein expression have been observed using pro-
of freeze–thawing. The extract was clarified by a short moters active during the late stage of viral replication.
microfuge spin (1 min, 14,000 rpm) and the supernatant We decided to incorporate the promoters corresponding
was analyzed for b-glu units as described by Miller to the constitutively expressed 7.5k gene (Mackett et al.,
(1972) as adapted for 96-well plates. The A405 values 1984) and a constitutively expressed synthetic promoter
were determined on a microplate reader (Dynatech EL noted for high-level expression (Chakrabarti and
MR3000), and b-glu activity was determined by compari- Moss, unpublished observation).
son to b-glu (Clontech) standards analyzed in the same A useful feature of vNotI/tk that must be retained in
assay. any new vector is the ability to discriminate for recombi-
nant viral genomes using selection against an active
thymidine kinase gene. The introduction of the ApaI site
Analysis of cytoxic T-cell response within the coding sequence for the tk gene necessitates
an increase in the total number of amino acids to accom-
Confluent monolayers of MC57G cells in wells of a 6- modate the restriction enzyme site. A comparison of the
well plate were infected at a m.o.i. of 1 with vEL/tk, v7.5/ amino acid sequence for thymidine kinase genes from
tk-ova, vEL/tk-ova, vEL/tk-ovaFL clone 1, and vEL/tk- a variety of animal and viral species showed the region
ovaFL clone 2 (vEL/tk-ovaFL are virus clones of full- of greatest heterogeneity was at the N terminus of the
length ovalbumin generated by direct ligation). At 16 h protein, suggesting that this region of the protein could
postinfection cells were harvested and labeled with 100 tolerate a modest increase in the number of amino acids.
mCi 51Cr (Dupont) for 1 h at 377, and 104 cells were added The recombination-independent cloning vectors were
to wells of a 96-well round-bottom plate in quadruplicate. constructed by making plasmid intermediates containing
A sample of uninfected MC57G cells incubated with 1 the modified thymidine kinase (tk) gene and replacing
mM purified ova 257–264 peptide was also incubated the tk sequence in the vNotI/tk genome by homologous
with 51Cr as a positive control and untreated MC57G cells recombination. Two sets of oligonucleotide pairs were
were used as a negative control. T cells specific for ova constructed that, when annealed, contained the promoter
257–264 were added to target cells at ratios of 2:1 and for the 7.5k gene or the synthetic EL sequence and re-
10:1. Cells were incubated at 377 for 4 h, supernatants striction sites for NotI and ApaI. The modified thymidine
were harvested, and 51Cr release was determined. Spon- kinase genes were constructed by annealing the double-
taneous release was derived by incubating target cells stranded oligonucleotides and ligating the product into
with medium alone and maximal release was determined the NotI site present at the beginning of the thymidine
by incubating target cells with 5% Triton X-100. Percent- kinase gene in pJNotI/tk, a plasmid containing the HindIII
age specific lysis was calculated using the formula % J fragment from vNotI/tk. The oligonucleotide pairs an-
specific lysis  [(experimental release 0 spontaneous nealed to and eliminated the NotI site in pJNotI/tk, gener-
release)/(maximal release 0 spontaneous release)] 1 ating a new NotI site closely followed by an ApaI site
100. In each case the mean of quadruplicate wells was after the promoter and flanking the nucleotides coding
for the initial methionine in the thymidine kinase gene,used in the formula.
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FIG. 1. Nucleotide sequences of p7.5/tk and pEL/tk. The nucleotide sequence of the promoter and beginning of the thymidine kinase gene for
v7.5/tk and vEL/tk.
resulting in plasmids p7.5/tk and pEL/tk (Fig. 1). The ac- generating a virus with the normal tk promoter. The v7.5/
quisition of the ApaI site was verified by restriction en- tk and vEL/tk genomes should contain a unique site for
zyme analysis of plasmid DNA and the nucleotide se- both NotI and ApaI within the HindIII J fragment. The
quence of the thymidine kinase gene promoter was de- genomic structure of the isolated virus stocks was ana-
termined and found to be as depicted in Fig. 1. lyzed by restriction enzyme digestion of DNA in agarose
The recombinant viruses derived from p7.5/tk and pEL/ plugs derived from virus-infected cells using NotI or ApaI
tk were isolated using a strategy relying on positive drug and electrophoresis of the products through 1% agarose
selection in the presence of HAT (hypoxanthine, (Fig. 2). Uncut vaccinia WR (lane 2) migrates at a size of
aminopterin, thymidine) (Weir et al., 1982). The viruses 190 kb as compared with multimers of bacteriophage l
vpNotI, a virus that contains a copy of pBR322 inserted (lane 1). After digestion with NotI, vaccinia WR is cleaved
at the NotI site of vNotI/tk (Merchlinsky and Moss, 1992), into two fragments approximately 150 and 40 kb in length
and vNotI/lacZ/tk, a virus with a copy of the lacZ gene (seventh lane from left), whereas vNot/tk, vEL/tk, and
interrupting the thymidine kinase in vNotI0 (Merchlinsky v7.5/tk were cleaved into fragments of about 110 and 80
and Moss, 1992), are thymidine kinase-negative (tk0) vi- kb. When the same samples were digested with ApaI,
ruses that are identical to vNotI/tk except for the inserted only one fragment the size of the uncut genome was
DNA at the beginning of the tk gene. The plasmids p7.5/ observed for both vaccinia WR and vNot/tk while vEL/tk
tk and pEL/tk were recombined with vpNotI and vNotI/ and v7.5/tk gave the same-sized fragments observed
lacZ/tk helper viruses in CV-1 cells and the infected after digestion with NotI. Therefore, both v7.5/tk and vEL/
monolayers were harvested and passaged in the pres- tk contain a unique site for both ApaI and NotI, the sites
ence of HAT medium on Hutk0 cells. Individual plaques are at the same locus as the NotI site in vNot/tk, and the
were passaged and isolated an additional three rounds sites are in a more central location in the genome than
on Hutk0 cells before expansion and analysis. the HindIII F fragment which contains the NotI site in
vaccinia WR. The background of cellular DNA fragments
Analysis of the structure of the viral genomes was more pronounced in the ApaI digestion, which has
a 6-bp recognition site, than in the NotI digest.The growth of v7.5/tk and vEL/tk virus in HAT supple-
The NotI and ApaI restriction sites in vEL/tk and v7.5/mented medium implies these viruses, in contrast to
tk were shown to be present within the vaccinia HindIIIvpNot and vNot/lacZ/tk, contain an active tk gene. How-
J fragment by Southern blot analysis of DNA from cellsever, an active tk gene could arise from multiple cross-
overs that delete the 7.5k or EL promoter sequences, infected with the viruses (data not shown). Also, the nu-
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comparison to vNotI/tk. The level of RNA synthesis was
measured by infecting confluent BSC-1 cells in the pres-
ence and absence of cytosine arabinoside (AraC) at a
m.o.i. of 5, harvesting the cells, isolating the RNA using
Trizol (Life Technologies), and analyzing the level of thy-
midine kinase RNA synthesis by primer extension (Weir
and Narayanan, 1990). Incubation with AraC blocks viral
DNA replication, allowing one to identify the class of viral
promoter. The early class of viral promoters is active
prior to DNA replication and will be unaffected by AraC
in the infection. Late promoters are expressed only after
the onset of DNA replication and their activity is abro-
gated in the presence of AraC. Perusal of the products
on a denaturing polyacrylamide gel demonstrated that
significantly more (estimated to be at least 10-fold) tk
RNA primer extension products were synthesized in vEL/
tk infections as compared with vNot/tk infections. In cells
infected with vNot/tk a single RNA start site insensitive
to AraC incubation was observed, whereas in vEL/tk in-
fections two distinct start sites, one resistant to AraC and
corresponding to the appropriate early start site (Davison
and Moss, 1989a) and one sensitive to AraC and corre-
sponding to the appropriate late start of RNA (Davison
and Moss, 1989b), were observed (data not shown). The
pattern of RNA species derived from infection with v7.5/tk
was similar to that observed for vEL/tk, with the absolute
levels of RNA expression intermediate to that observed
for vEL/tk and vNot/tk.
To verify the levels of expression for genes inserted
into the viral vectors the E. coli gusA gene encoding for
b-glu was cloned into vNotI/tk, v7.5/tk, and vEL/tk viral
vectors and the relative promoter strength was mea-
sured. The DNA fragment encoding for the b-glu geneFIG. 2. Restriction enzyme analysis of virus genomes using CHEF
gel. BSC-1 cells were infected at a m.o.i. of approximately 10 PFU/cell was inserted into plasmids containing each promoter,
by vaccinia WR, vEL/tk, v7.5/tk, or vNotI/tk. After 24 h the cells were generating pJNot/tk-GUS, p7.5/tk-GUS, and pEL/tk-GUS.
harvested and formed into agarose plugs. The plugs were equilibrated The correct orientation of the insert b-glu gene in pJNot/
in the appropriate restriction enzyme buffer and 1 mM PMSF for 16 h
tk was verified by restriction enzyme analysis. The plas-at room temperature; incubated with restriction enzyme buffer, 100 ng/
mids containing b-glu were recombined with vNotI/tkml bovine serum albumin, and 50 units NotI or ApaI for 2 h at 377 (NotI)
or room temperature (ApaI); and electrophoresed in a 1.0% agarose (Earl and Moss, 1991) and recombinant virus was identi-
gel on a Bio-Rad CHEFII apparatus for 15 h at 6 V/cm with a switching fied by incubation of the monlayers with 5-bromo-4-
time of 15 s. The leftmost sample contains l DNA, the second sample chloro-3-indolylglucuronide (X-glu) (Carroll and Moss,
contains undigested vaccinia DNA, and the remainder of the samples
1995). The recombinant viruses were passaged for threecontain the DNA samples described above each well digested with
rounds through Hutk0 cells and expanded to generateApaI or NotI, where vEL refers to vEL/tk and v7.5 refers to v7.5/tk. The
lower portion of the figure is a schematic map showing the location the viral stocks vNotI/tk-GUS, v7.5/tk-GUS, and vEL/tk-
of the NotI and ApaI sites in each virus. GUS. The structures of the recombinant viruses were
verified by Southern blot analysis (data not shown).
The level of expression of b-glu by vNotI/tk-GUS, v7.5/
cleotide sequence of the promoter region in v7.5/tk and tk-GUS, and vEL/tk-GUS was measured from infected
pEL/tk was determined from DNA fragments derived from confluent monolayers of BSC-1 cells in the presence or
PCRs using primers flanking the promoter for the thymi- absence of AraC (Fig. 3). The level of b-glu expression
dine kinase gene and shown to match the sequence for v7.5/tk-GUS and vEL/tk was much higher than that
displayed in Fig. 1. observed for vNotI/tk-GUS and highest (approximately
20-fold higher) in vEL/tk-GUS. Expression of b-glu wasQuantitation of promoter activity
observed for all three viruses in the presence of cytosine
arabinoside, indicating that each promoter is a memberThe v7.5/tk and vEL/tk vectors have been designed to
constitutively express elevated levels of insert protein in of the early class of viral promoters. The level of b-glu
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vNotI/lacZ/tk (data not shown) or affect the viability of
the Hutk0 cell line.
Construction of recombinant virus by direct ligation
Direct ligation vectors will be useful for the generation
of complex expression libraries only if the production of
infectious virus from the naked DNA is facile and effi-
cient. Previously, helper virus activity was supplied in
cells transfected with DNA ligation products by coinfec-
tion with conditionally lethal temperature-sensitive virus
(Merchlinsky and Moss, 1992) or fowlpox (Scheiflinger
et al., 1992). Since high levels of replicating wild-type
virus interfere with the ability to package viral DNA and
vaccinia virus can recombine with the input DNA, only
conditionally defective vaccinia virus can be used as
helper (Merchlinsky and Moss, 1992). Fowlpox should
be a superior helper virus as it is used at 377, will not
revert to a highly replicating strain, and, because it does
not recombine with vaccinia DNA or productively infect
primate cell lines, can be used at a higher m.o.i. than
FIG. 3. Promoter strength of recombinant viruses. The units of b- vaccinia. To determine if fowlpox can serve as an effi-
glucuronidase activity were determined as described by Miller (1972) cient helper virus a series of wells from a 12-well plate
as adapted for 96-well plates. The A405 values were determined on a containing BSC-1 cells were infected with varying m.o.i.
microplate reader (Dynatech MR3000) and the b-glucuronidase activity
of fowlpox and transfected with full-length vaccinia WRwas determined by comparison with b-glucuronidase (Clontech) stan-
DNA; the cells were harvested after 24, 48, or 72 h anddards analyzed in the same assay.
the virus titer was determined. Transfection of DNA or
fowlpox infection alone resulted in no plaques. The yield
in vNotI/tk-GUS was unchanged in the presence or ab- of vaccinia virus, as measured by plaque assay, in-
sence of AraC, indicating that this promoter is active only creased with later harvest and was proportional to the
early during infection, whereas the b-glu levels in v7.5/ m.o.i. of the fowlpox infection.
tk-GUS and vEL/tk-GUS were lower in the presence of A 1.1-kb fragment of the ovalbumin cDNA (Pulaski et
AraC, indicating these promoters are active both early al., 1996) was used as a model insert to study the genera-
and late during infection. tion of functional recombinant virus by direct ligation.
The ovalbumin insert was modified as described under
Materials and Methods to include a NotI site at its 5*Bromodeoxyuridine sensitivity of virus vectors
end, translation stop codons, a vaccinia transcription
stop signal, and an ApaI site at its 3 * end. This insertThe v7.5/tk and vEL/tk vectors were initially isolated
by growth in the presence of HAT supplemented medium was digested with NotI and ApaI and ligated with purified
vEL/tk DNA arms that had been digested with NotI andand are designed to contain an active tk gene to allow
selection for viruses with inserts via passage in Hutk0 ApaI. The ligation mix was transfected into fowlpox-in-
fected BSC-1 cells, the infected cells were harvested,cells in the presence of bromodeoxyuridine (Earl and
Moss, 1991). Both vectors were tested by plaque assay and after 3 days, the cell extract was passaged on Hutk0
cells in the presence or absence of 125 mM bromodeoxy-in Hutk0 cells using drug selection. Incubation without
drug or with HAT supplement at a concentration suffi- uridine. The titer obtained without drug selection was 2.7
1 103 PFU, and that with drug selection, 2.8 1 103 PFU.cient to interfere with plaque formation for vpNot or vNot/
lacZ/tk, (data not shown) gave an equivalent number of Individual plaques were picked from Hutk0 cells in the
presence and absence of bromodeoxyuridine and testedlike-sized plaques. Surprisingly, an equal number of
plaques, albeit much smaller in size, were observed for for the presence of the ovalbumin insert by dot-blot hy-
bridization with an ovalbumin cDNA probe. All 15 plaquesvEL/tk with incubation in 25 mM bromodeoxyuridine, a
concentration sufficient to interfere with the ability of vac- picked in the presence of bromodeoxyuridine and all 10
plaques picked in its absence contained the ovalbumincinia WR to plaque on Hutk0 cells (data not shown).
Addition of 125 mM bromodeoxyuridine was sufficient to insert. These viruses were named vEL/tk-ovaFL. Two in-
dividual clones were expanded further and tested for theinhibit plaque formation for vEL/tk and v7.5/tk (data not
shown). The higher concentration of bromodeoxyuridine ability to sensitize host cells to lysis by ova 257–264-
specific cytotoxic T lymphocytes (CTLs). The results ofdid not interfere with the growth of tk0 viruses such as
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TABLE 1 karyotic cells as they are easily constructed and engi-
neered to express foreign proteins at high levels. TheCML Assay on Recombinant Vaccinia Virus-Infected Cells
wide host range of the virus allows one to faithfully ex-
Effector:target ratio press proteins in a variety of cell types. Direct cloning
strategies have been devised to extend the scope of
MC57G cells 2:1 10:1 applications for poxvirus viral chimeras in which the re-
combinant genomes are constructed in vitro by directPercentage specific lysis
ligation of DNA fragments to vaccinia ‘‘arms’’ and trans-Untreated 01.3 01.3
ova 257–264 peptide, 1 mM 54 83 fection of the DNA mixture into cells infected with a
vEL/tk 00.5 0 helper virus (Merchlinsky and Moss, 1992; Scheiflinger
v7.5/tk-ova, homologous recombination 50 78 et al., 1992). This approach has been used for high-level
vEL/tk-ova, homologous recombination 47 71
expression of foreign proteins (Pfleiderer et al., 1995) andvEL/tk-ovaFL, direct ligation clone 1 48 70
to efficiently clone fragments as long as 26 kb (Merchlin-vEL/tk-ovaFL, direct ligation clone 2 46 74
sky and Moss, 1992).
Note. Virally infected MC57G cells were generated as described Use of the thymidine kinase gene as the insertion site
under Materials and Methods. One sample of MC57G cells was treated for foreign DNA in the viral vectors allows implementation
with ova 257–264 peptide (1 mM); another sample of cells was left
of selection protocols for distinguishing recombinantsuntreated. Cells were incubated with two different ratios of ova-specific
from helper or wild-type genomes. The level of tk expres-cytotoxic T lymphocytes for 4 h at 377 and percentage specific lysis
was determined as described under Materials and Methods. sion in v7.5/tk and vEL/tk should be much higher than in
vaccinia WR or vNot/tk. However, the ApaI site at the
beginning of the tk gene in v7.5/tk and vEL/tk was formed
this experiment are shown in Table 1. As controls, vac-
from vNot/tk by adding extra nucleotides at the NotI site.
cinia recombinants for an ova 257–264 minigene, v7.5/
The additional nucleotides increase the amino acid se-
tk-ova and vEL/tk-ova, were generated by homologous
quence at the N terminus of the wild-type tk gene from
recombination. These ova peptide recombinant viruses
Met–Asn–Gly to Met–Gly–Pro–Ala–Ala–Asn–Gly in
were tested in concert with the vEL/tk-ovaFL clones for
v7.5/tk and vEL/tk. Modifications in the expression level
the ability to sensitize host cells to lysis by ova-specific
and N-terminal amino acid sequence of the thymidine
CTLs. As shown in Table 1, infection with either full-
kinase enzyme may increase (more protein) or decrease
length or minigene ovalbumin vaccinia recombinants
(different sequence) the sensitivity of the virus to bromo-
was as efficient as pulsing with 1 mM purified ova 257 –
deoxyuridine. Plaques, albeit smaller, were observed
264 peptide for sensitization of target cells to lysis by
with v7.5/tk and vEL/tk infection at a concentration of
ova-specific CTLs.
bromodeoxyuridine sufficient to completely suppress
plaque formation for wild-type vaccinia WR. Plaque for-
DISCUSSION
mation was suppressed at fivefold higher concentrations
of bromodeoxyuridine, a level of drug that does not inter-Large DNA viruses are particularly useful expression
vectors for the study of cellular processes as they can fere with the viability of the cells or impede the ability of
tk0 virus to form plaques. The explanation for the alteredexpress many different proteins in their native form in a
variety of cell lines. The gene of interest is normally sensitivity to bromodeoxyuridine awaits further charac-
terization of the protein as the altered thymidine kinasecloned in a plasmid under the control of a promoter
flanked by sequences homologous to a nonessential re- enzyme may have a different reaction rate for formation
of the monophosophate form of the bromodeoxyuridinegion in the virus and the cassette is introduced into the
genome via homologous recombination. A panopoly of or a reduced ability to bind bromodeoxyuridine.
The application of v7.5/tk and vEL/tk to protocols forvectors for expression, selection, and detection have
been devised to accommodate a variety of cloning and construction of complex expression libraries requires ef-
ficient production of recombinants and strong selectionexpression strategies. However, homologous recombi-
nation is an ineffective means of making a recombinant to eliminate or minimize wild-type and contaminants. The
use of two restriction sites allows one to design cloningvirus in situations requiring the generation of complex
libraries or when the insert DNA is large. An alternative strategies for the oriented cloning of DNA fragments
such as products of PCR (Pfleiderer et al., 1995) andstrategy for the construction of recombinant genomes
relying on direct ligation of viral DNA ‘‘arms’’ to an insert increases the frequency of the desired recombinant as
wild-type genomes are no longer generated by ligationand the subsequent rescue of infectious virus has been
explored for the genomes of poxvirus (Merchlinsky and of vaccinia arms. When v7.5/tk or vEL/tk DNA previously
digested with NotI and ApaI was transfected into cellsMoss, 1992; Pfleiderer et al., 1995; Scheiflinger et al.,
1992), herpesvirus (Rixon and McLauchlan, 1990), and infected with fowlpox the virus titer was 100-fold lower
than for intact uncut DNA (data not shown). Also, allbaculovirus (Ernst et al., 1994).
Poxviruses are ubiquitous vectors for studies in eu- plaques isolated in the presence and absence of bromo-
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Ernst, W. J., Grabherr, M. R., and Katinger, H. W. D. (1994). Direct cloningdeoxyuridine (15 with bromodeoxyuridine and 10 without)
into the Autographa californica nuclear polyhedrosis virus for genera-during the isolation of vEL/tk-ovaFL contained the oval-
tion of recombinant baculoviruses. Nucleic Acids Res. 22, 2855–
bumin insert. The efficiency of infectious virus formation 2856.
increased with the amount of fowlpox helper up to at Mackett, M., Smith, G. L., and Moss, B. (1984). General method for
production and selection of infectious vaccinia virus recombinantsleast a m.o.i. of 1. Also, transfection of large DNA frag-
expressing foreign genes. J. Virol. 49, 857–864.ments varies with the type and preparation of lipid (M.
Merchlinsky, M., and Moss, B. (1989). Resolution of vaccinia virus DNACarroll, personal communication) and we are presently
concatemer junctions requires late gene expression. J. Virol. 63,
assaying different lipid mixtures and cell types as well 1595–1603.
as investigating other parameters to find optimum condi- Merchlinsky, M., and Moss, B. (1992). Introduction of foreign DNA into
the vaccinia genome by in vitro ligation: Recombination-independenttions for the direct ligation protocol. The v7.5/tk and vEL/
selectable cloning vectors. Virology 190, 522–526.tk vectors provide a set of universally applicable direct
Miller, J. (1972). ‘‘Experiments in Molecular Genetics.’’ Cold Spring Har-
ligation cloning vectors for poxviruses. bor Laboratory, Cold Spring Harbor, NY.
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